Slide One
Slide One

Providing lasting relief for your horse with Navicular syndrome.

  • Control clinical signs
  • Long-lasting
  • Effective
  • Safe
cause for pain

Restores Balance in the Bone

Managing the clinical signs of navicular syndrome in horses can present a challenge. Yet, with more than 250,000 doses administered worldwide in the last 12 years, Tildren® (tiludronate disodium) offers a proven option for veterinarians and horse owners. Indicated for the control of clinical signs associated with navicular syndrome in horses four years and older, Tildren® restores balance to the process of bone remodeling.

Lameness Can Be a Complex Problem

If you suspect your horse is having issues, speak with your veterinarian about diagnosis and treatment plans. Depending on the diagnosis, Tildren® may be right for your horse.

Do not use in horses with impaired renal function or with a history of renal disease. NSAIDs should not be used concurrently with TILDREN® . Concurrent use of NSAIDs with TILDREN® may increase the risk of renal toxicity and acute renal failure. Horses should be observed closely for 4 hours post-infusion for the development of clinical signs consistent with colic or other adverse reactions.

Caution should be used when administering TILDREN® to horses with conditions affecting mineral or electrolyte homeostasis (e.g. HYPP, hypocalcemia) and conditions which may be exacerbated by hypocalcemia (e.g. cardiac disease). The safe use of TILDREN® has not been evaluated in horses less than 4 years of age, in pregnant or lactating mares, or in breeding horses. See package insert for full prescribing information.